Rigel Announces Conference Call and Webcast to Report Third Quarter 2023 Financial Results and Business UpdatePRNewsWire • 10/31/23
Rigel Reports Second Quarter 2023 Financial Results and Provides Business UpdatePRNewsWire • 08/01/23
Rigel Announces Conference Call and Webcast to Report Second Quarter 2023 Financial Results and Business UpdatePRNewsWire • 07/25/23
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)PRNewsWire • 07/05/23
Rigel Announces Presentation of Data from Analysis of REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AMLPRNewsWire • 06/07/23
Rigel Announces Poster Presentation at the Upcoming 2023 American Society of Clinical Oncology Annual MeetingPRNewsWire • 06/01/23
Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/02/23
Rigel Announces Conference Call and Webcast to Report First Quarter 2023 Financial Results and Business UpdatePRNewsWire • 04/25/23
Rigel Pharmaceuticals (RIGL) Q4 Earnings and Revenues Surpass EstimatesZacks Investment Research • 03/07/23
Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatePRNewsWire • 03/07/23
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2022 Financial Results and Business UpdatePRNewsWire • 02/28/23